VMS Capital
VC Fund
San Diego, United States
VMS Capital is a finance & lending solutions business located in San Diego, California. VMS Capital specializes in assisting business owners access the capital they require to grow their business, refinance their existing loans, or to capitalize on new business acquisition opportunities. VMS capital can assist you with financing when yourcompany is turned down by a local bank or financial institution. VMS Capital has relationships with numerous national lenders with less intrusive qualifying requirements and faster approvals on loan applications.VMS Capital offers a wide range of finance products, such as SBA loans, Unsecured lines of credit, Merchant cash advance loans, Equipment leasing, Sale-leaseback, Account Receivable financing, Asset based lines of credit, Contract finance, Commercial real estate loans for acquisition financing or refinancing of existing loans with balloon payments approaching, Bridge loans, hard money loans, etc.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries VMS Capital invests in
Stages VMS Capital invests in
Countries VMS Capital invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Rob Stoddard
|
|||
Vera Stoddard
|
|||
Investment Focus
Industry
- Biotechnology 2 (100%)
- Events 1 (50%)
- Medical 1 (50%)
- Hospital 1 (50%)
- Biopharma 1 (50%)
Stage
- Series A 1 (50%)
- Series B 1 (50%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Rob Stoddard
Vice President
|
Vice President | Total investments: 0 | Find email | |
|
Vera Stoddard
President
|
President | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
JADE Biomedical
|
Jade Biomedical provides regulatory and analytical testing services to biopharmaceutical companies worldwide. It is the world's first registered biologics contract organisation, Bio-CQOR. JADE's founder and leaders have extensive drug agency experience, including NMPA, FDA, EMA, PMDA, and PICS. Their expertise covers all therapeuticplatforms, including monoclonal antibodies, antibody-drug-conjugates, cell and gene therapies. | Series B / Sep 15, 2022 | |
St Phi Therapeutics
|
Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy. | Series A / Jan 11, 2022 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does VMS Capital invest in?
VMS Capital invests primarily in Biotechnology, Events and Medical startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact VMS Capital?
Public channels for VMS Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at VMS Capital?
The team at VMS Capital includes Rob Stoddard (Vice President) and Vera Stoddard (President). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
